Simultaneous integrated boost with intensity modulated radiation therapy in brain oligometastases: A feasible technique for developing countries
Authors:
Open Access
- 1 January 2015
- journal article
- Published by Scientific Scholar in South Asian Journal of Cancer
- Vol. 04 (01) , 011-014
Abstract
Introduction: To analyze the pattern of brain metastasis (BM), and to use intensity modulated radiation therapy (IMRT) for target dose escalation in cases with ≤3 metastatic lesions (oligometastases). Materials and Methods: Thirty-two consecutive cases of BM treated during September 2009 to August 2012 were analyzed retrospectively. Results: The study comprised 13 males (40.62%) and 19 females (59.37%). Thirteen (40%) patients presented with disseminated intracranial metastases, while 19 (60%) had ≤3 foci. In 25 cases (78%), the primary was located either in the breast (14 cases) or lung (11 cases). The 13 patients with disseminated intracranial metastases received whole brain radiation therapy to a dose of 30 Gy/10-12 daily fractions (Group A) while the 19 cases with ≤3 lesions received an additional dose of 6-10 Gy to gross lesions using a simultaneous integrated boost (SIB) with IMRT thus receiving a total dose of 36-40 Gy/12-15 fractions (Group B). Overall survival (OS) for the breast primary was 6.3 and lung primary was 5.3 months, respectively. The mean OS for breast cases in Group B was higher (9.5 months) as compared to Group A cases (1.9 months) and was statistically significant (P = 0.0056). Similarly, primary lung cancer cases in Group B showed a mean OS of 8.75 months versus 2.6 months for Group A cases (P = 0.213). Conclusions: IMRT is a safe and effective technique in cases with oligometastases for dose escalation in the form of SIB.Keywords
This publication has 17 references indexed in Scilit:
- Quality of life and symptoms control in brain metastasis after palliative whole brain radiotherapy using two different protocols.2012
- Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasisStrahlentherapie und Onkologie, 2012
- The Role of Surgery, Radiosurgery and Whole Brain Radiation Therapy in the Management of Patients with Metastatic Brain TumorsInternational Journal of Surgical Oncology, 2011
- Simultaneous in-field boost for patients with 1 to 4 brain metastasis/es treated with volumetric modulated arc therapy: a prospective study on quality-of-lifeRadiation Oncology, 2011
- IsoBED: a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) techniqueJournal of Experimental & Clinical Cancer Research, 2011
- The developing role for intensity-modulated radiation therapy (IMRT) in the non-surgical treatment of brain metastasesBritish Journal of Radiology, 2010
- Role of radiotherapy in cancer control in low-income and middle-income countriesThe Lancet Oncology, 2006
- Brain metastasesCurrent Opinion in Neurology, 2005
- Stereotactic radiosurgery for brain oligometastases: good for some, better for all?Annals of Oncology, 2005
- Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialThe Lancet, 2004